|
1
|
Sweetnam R: Osteosarcoma. Br J Hosp Med.
28(112): 116–121. 1982.
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Damron TA, Ward WG and Stewart A:
Osteosarcoma, chondrosarcoma, and Ewing's sarcoma. National Cancer
Data Base report. Clin Orthop Relat Res. 459:40–47. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dorfman HD and Czerniak B: Bone cancers.
Cancer. 75:(1 Suppl). S203–S210. 1995. View Article : Google Scholar
|
|
6
|
Geller DS and Gorlick R: Osteosarcoma: A
review of diagnosis, management, and treatment strategies. Clin Adv
Hematol Oncol. 8:705–718. 2010.PubMed/NCBI
|
|
7
|
Bielack SS, Marina N, Ferrari S, Helman
LJ, Smeland S, Whelan JS and Reaman GH: Osteosarcoma: The same old
drugs or more? J Clin Oncol. 26:3102–3103; author reply 3104–3105.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chou AJ, Geller DS and Gorlick R: Therapy
for osteosarcoma: Where do we go from here? Paediatr Drugs.
10:315–327. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
O'Day K and Gorlick R: Novel therapeutic
agents for osteosarcoma. Expert Rev Anticancer Ther. 9:511–523.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bernthal NM, Federman N, Eilber FR, Nelson
SD, Eckardt JJ, Eilber FC and Tap WD: Long-term results (>25
years) of a randomized, prospective clinical trial evaluating
chemotherapy in patients with high-grade, operable osteosarcoma.
Cancer. 118:5888–5893. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Link MP, Goorin AM, Miser AW, Green AA,
Pratt CB, Belasco JB, Pritchard J, Malpas JS, Baker AR, Kirkpatrick
JA, et al: The effect of adjuvant chemotherapy on relapse-free
survival in patients with osteosarcoma of the extremity. N Engl J
Med. 314:1600–1606. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sandberg R, Neilson JR, Sarma A, Sharp PA
and Burge CB: Proliferating cells express mRNAs withshortened 3′
untranslated regions and fewer microRNA target sites. Science.
320:1643–1647. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mayr C and Bartel DP: Widespread
shortening of 3′UTRs by alternative cleavage and polyadenylation
activates oncogenes in cancer cells. Cell. 138:673–684. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ji Z, Lee JY, Pan Z, Jiang B and Tian B:
Progressive lengthening of 3′ untranslated regions of mRNAs by
alternative polyadenylation during mouse embryonic development.
Proc Natl Acad Sci USA. 106:7028–7033. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mangone M, Manoharan AP, Thierry-Mieg D,
Thierry-Mieg J, Han T, Mackowiak SD, Mis E, Zegar C, Gutwein MR,
Khivansara V, et al: The landscape of C. elegans 3′UTRs. Science.
329:432–435. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jacobson A and Peltz SW:
Interrelationships of the pathways of mRNA decay and translation in
eukaryotic cells. Annu Rev Biochem. 65:693–739. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wickens M, Anderson P and Jackson RJ: Life
and death in the cytoplasm: Messages from the 3′ end. Curr Opin
Genet Dev. 7:220–232. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Garneau NL, Wilusz J and Wilusz CJ: The
highways and byways of mRNA decay. Nat Rev Mol Cell Biol.
8:113–126. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
McCracken S, Fong N, Rosonina E, Yankulov
K, Brothers G, Siderovski D, Hessel A, Foster S, Shuman S and
Bentley DL: 5′-Capping enzymes are targeted to pre-mRNA by binding
to the phosphorylated carboxy-terminal domain of RNA polymerase II.
Genes Dev. 11:3306–3318. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hirose Y and Manley JL: RNA polymerase II
is an essential mRNA polyadenylation factor. Nature. 395:93–96.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi Y, Di Giammartino DC, Taylor D,
Sarkeshik A, Rice WJ, Yates JR III, Frank J and Manley JL:
Molecular architecture of the human pre-mRNA 3′ processing complex.
Mol Cell. 33:365–376. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Masamha CP, Xia Z, Yang J, Albrecht TR, Li
M, Shyu AB, Li W and Wagner EJ: CFIm25 links alternative
polyadenylation to glioblastoma tumour suppression. Nature.
510:412–416. 2014.PubMed/NCBI
|
|
23
|
Elkon R, Drost J, van Haaften G, Jenal M,
Schrier M, Vrielink JA Oude and Agami R: E2F mediates enhanced
alternative polyadenylation in proliferation. Genome Biol.
13:R592012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pasquinelli AE, Reinhart BJ, Slack F,
Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B,
Müller P, et al: Conservation of the sequence and temporal
expression of let-7 heterochronic regulatory RNA. Nature.
408:86–89. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Reinhart BJ, Slack FJ, Basson M,
Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR and Ruvkun G:
The 21-nucleotide let-7 RNA regulates developmental timing in
Caenorhabditis elegans. Nature. 403:901–906. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kobayashi E, Satow R, Ono M, Masuda M,
Honda K, Sakuma T, Kawai A, Morioka H, Toyama Y and Yamada T:
MicroRNA expression and functional profiles of osteosarcoma.
Oncology. 86:94–103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Osaki M, Takeshita F, Sugimoto Y, Kosaka
N, Yamamoto Y, Yoshioka Y, Kobayashi E, Yamada T, Kawai A, Inoue T,
et al: MicroRNA-143 regulates human osteosarcoma metastasis by
regulating matrix metalloprotease-13 expression. Mol Ther.
19:1123–1130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Duan Z, Choy E, Harmon D, Liu X, Susa M,
Mankin H and Hornicek F: MicroRNA-199a-3p is downregulated in human
osteosarcoma and regulates cell proliferation and migration. Mol
Cancer Ther. 10:1337–1345. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Meng F, Henson R, Wehbe-Janek H, Ghoshal
K, Jacob ST and Patel T: MicroRNA-21 regulates expression of the
PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology. 133:647–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jovanovic M and Hengartner MO: miRNAs and
apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Deng G, Hu C, Zhu L, Huang F, Huang W, Xu
H and Nie W: Downregulation of ROS-FIG inhibits cell proliferation,
colony-formation, cell cycle progression, migration and invasion,
while inducing apoptosis in intrahepatic cholangiocarcinoma cells.
Int J Mol Med. 34:661–668. 2014.PubMed/NCBI
|
|
37
|
Zhang ZG, Niu XY, He XJ and Shu J:
Ginsenoside Rg1 reduces toxicity of fine particulate matter on
human alveolar epithelial cells: A preliminary observation. Mol Med
Rep. 9:989–992. 2014.PubMed/NCBI
|
|
38
|
Tsujimoto M, Doi T, Kuroyanagi G, Yamamoto
N, Matsushima-Nishiwaki R, Iida Y, Enomoto Y, Iida H, Ogura S,
Otsuka T, et al: αB-crystallin reduces ristocetin-induced soluble
CD40 ligand release in human platelets: Suppression of thromboxane
A2 generation. Mol Med Rep. 12:357–362. 2015.PubMed/NCBI
|
|
39
|
Zhang F, Li ZL, Xu XM, Hu Y, Yao JH, Xu W,
Jing HR, Wang S, Ning SL and Tian XF: Protective effects of
icariin-mediated SIRT1/FOXO3 signaling pathway on intestinal
ischemia/reperfusion-induced acute lung injury. Mol Med Rep.
11:269–276. 2015.PubMed/NCBI
|
|
40
|
Bekker-Méndez C, Guzmán-Aguilar RM,
Hernández-Cueto MA, Huerta-Yepez S, Jarillo-Luna RA,
González-Veyrand E and González-Bonilla CR: TUNEL-positive cells in
the surgical border of an amputation due to infected diabetic foot.
Mol Med Rep. 5:363–372. 2012.PubMed/NCBI
|
|
41
|
Ji F, Zhang H, Wang Y, Li M, Xu W, Kang Y,
Wang Z, Wang Z, Cheng P, Tong D, et al: MicroRNA-133a,
downregulated in osteosarcoma, suppresses proliferation and
promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone. 56:220–226.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang H, Cai X, Wang Y, Tang H, Tong D and
Ji F: microRNA-143, down-regulated in osteosarcoma, promotes
apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol
Rep. 24:1363–1369. 2010.PubMed/NCBI
|
|
43
|
Zhu S, Wu H, Wu F, Nie D, Sheng S and Mo
YY: MicroRNA-21 targets tumor suppressor genes in invasion and
metastasis. Cell Res. 18:350–359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gorlick R: Current concepts on the
molecular biology of osteosarcoma. Cancer Treat Res. 152:467–478.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bacci G, Bertoni F, Longhi A, Ferrari S,
Forni C, Biagini R, Bacchini P, Donati D, Manfrini M, Bernini G and
Lari S: Neoadjuvant chemotherapy for high-grade central
osteosarcoma of the extremity. Histologic response to preoperative
chemotherapy correlates with histologic subtype of the tumor.
Cancer. 97:3068–3075. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jianwei Z, Fan L, Xiancheng L, Enzhong B,
Shuai L and Can L: MicroRNA 181a improves proliferation and
invasion, suppresses apoptosis of osteosarcoma cell. Tumour Biol.
34:3331–3337. 2013. View Article : Google Scholar : PubMed/NCBI
|
